Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4368_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
98 Мб
Скачать
Nasopharyngectomy
https://t.me/med1917
enhancement (FICE) and autofluorescence imaging.34 These technologies have been developed to improve mucosal visualization and to enhance or complement traditional white light endoscopy. Narrow-band imaging using a blue light filter highlights superficial mucosal vasculature. The blue filter corresponds to the peak absorption spectrum of hemoglobin and further enhances visualization of mucosal vasculature. Therefore, narrow-band imaging is a useful tool to detect the neoangiogenesis of early malignant mucosal
35,36
lesions.
NPCs demonstrate an irregular engorged vascular pattern, a microvascular proliferative pattern, absence of surface patterns, and/or a “‘reverse’ haphazard follicular pattern” with a dark brown center and pale periphery.
37,38
Narrow-band imaging has a reported sensitivity of 78 to 93.9%, specificity of 95.5%, positive predictive value of 97%, and negative predictive value of 70 to 98.1%.
34,37,39
Chemoendoscopy uses a filter to restrict incident wavelengths to correspond to the absorption peaks of hemoglobin (415–540 nm) which improves the contrast between the vasculature and mucosa.
34
FICE or i-scan applies an image processing algorithm to white light images based on spectral emission methods and has a high sensitivity and specicificity.
34
Autofluorescence endoscopy sequentially radiates both excitation light (370–470 nm) and green light (540–560 nm) which excites endogenous fluorophores (e.g., collagen). Dysplasia or early invasive malignancies are displayed as magenta on a pseudocolor image.
34
Autofluorescence
34
has a reported accuracy for distinguishing between hyperplastic colonic polyps and adenomas of up to 88.4%; however, it has been shown to have a high false-positive rate of up to 81%.
34
Finally, confocal laser endomicroscopy uses laser light focused through a pinhole to improve image resolution to a subcellular level and has a sensitivity and specificity that ranges between 76 and 97% and 72 and 99%, respectively.
Surgery does offer comparable or better local control rates than re-irradiation treatment modality for radioresistant tumors.
34
4,11,12,14,40–42
and is the primary
2,18,19
Endoscopic surgery results in less severe complications, less intraoperative blood loss, shorter operating times, and a shorter length of stay when compared with open surgery. re-irradiation,
43
Surgery also results in less morbidity than
11,14,15
which often produces significant complications and sequelae such as neck fibrosis, deafness, trismus, cranial neuropathies, endocrine dysfunction, and temporal lobe necrosis.
44
However, surgery is limited to a select group of patients. Patients who present with significant involvement of the ICA or extension into the cavernous sinus or spine are not
surgical candidates, as surgery will cause significant morbidity and will not alter the outcome.
26.6 Contraindications to Surgery and Complications
We have described an endoscopic endonasal approach to nasopharyngeal tumors; however, open and combined approaches are also viable options, depending on the tumor type, location, and extent. Castelnuovo et al have developed a grading system of surgical resection according to the extent of the disease (Table 26.1).45 Endonasal approaches have the advantage of utilizing the preexistent sinonasal air spaces and provide magnified access to the central skull base without the need for external incisions, translocation/disruption of the maxillofacial skeleton, and excessive dissection as part of the approach. Endoscopic nasopharyngectomy can achieve negative margins in up to 97% of appropriately selected patients. are extremely selected, as endoscopic approaches are limited by their relationship to critical neurovascular structures such as the ICA and optic nerves. A pure endoscopic approach is limited/contraindicated for tumors surrounding the parapharyngeal ICA or extending posterior to the parapharyngeal or petrous ICA. Some authors have suggested that there be a distance of at least 1 cm between the tumor and the ICA for it to be considered endoscopically resectable. Other authors have suggested only rT1, rT2, and select rT3 tumors with limited skull base, brain, or dural involvement are amenable to endoscopic resection. However, Al-Sheibani et al demonstrated that endoscopic approaches can be used for T3 and T4 tumors adjacent to but not involving the ICA. Therefore, there are no absolute guidelines regarding the approach chosen.
Extensive dural involvement is also a relative contraindication to an endonasal approach. Certain key features on MRI have been shown to be highly predictive of dural invasion. These features include pial enhancement, loss of the hypointense zone, discontinuous dural enhancement, focal dural nodules, and more than 2 to 5 mm of dural thickening. approaches range in their exposure and morbidity but can be divided in two main categories according to their direction of approach, lateral and anterior. Lateral approaches include the pre- and postauricular approaches, usually involving orbitozygomatic
2,46
However, patients
2
and Castelnuovo et al17
48–50
Open
47
43
Table 26.1 Classifi cation of surgical resection by extent of disease
NER subtype Surgical resection
1 Posterior septectomy, resection of posterosuperior nasopharyngeal wall to, but not including, the bone fl oor of
2 Resection includes fl oor and anterior wall of sphenoid sinus
3 Resection includes lateral wall of nasopharynx and car tilaginous eustachian tube
Abbreviation: NER, nasopharyngeal endoscopic resection. Source: Castelnuovo et al.
the sphenoid sinus superiorly and pharyngobasilar/prevertebral fascia posteriorly. Ventral clivus is drilled down. Cartilaginous eustachian tube is preserved
45
275
Nasopharyngectomy
https://t.me/med1917
osteotomies and a subtemporal craniectomy. In addition, the postauricular approach involves a transtemporal corridor. Anterior approaches include the midfacial degloving Le Forte I osteotomy, the facial translocation or maxillary swing approach, and the transcervical­mandibulotomy-palatal approach. However, a large open approach does not equate a corresponding increase of exposure in the nasopharynx, as they often provide limited access. Morbidity associated with open approaches occurs in up to 54% of patients and includes velopharyngeal incompetence, palatal dysfunction, and trismus.
the development of transoral robotic-assisted surgery.
11,12
Future directions for nasopharyngeal surgery include
51–53
Robotic surgery does not require transection of the palate to access the nasopharynx; however, this technique is still limited by the lack of devices that allow the resection of bone and adequate suction.
26.7 Conclusion
An endoscopic endonasal approach to nasopharyngeal tumors offers excellent access and visualization to this difficult region. An EEA also provides the ability to adequately control critical neurovascular structures, appropriate oncologic resection with negative margins, the ability to reconstruct with nearby pedicled vascularized tissue, no external scars, and maximal preservation of function. In select patients and with an experienced team with specialized equipment, this approach offers comparable, if not superior, outcomes to traditional open approaches.
References
1. Brown JJ, Fee WE. Surgical resection of the nasopharynx. Oper Tech Otolaryngol 2010;21(1):26–34
2. Al-Sheibani S, Zanation AM, Carrau RL, et al. Endoscopic en­donasal transpterygoid nasopharyngectomy. Laryngoscope 2011;121(10):2081–2089
3. Lin J-C, Jan J-S, Hsu C-Y, Liang W-M, Jiang R-S, Wang W-Y. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 2003;21(4):631–637
4. Yu KH, Leung SF, Tung SY, et al; Hong Kong Nasopharyngeal Carcinoma Study Group. Survival outcome of patients with na­sopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Head Neck 2005;27(5):397–405
5. Sanguineti G, Geara FB, Garden AS, et al. Carcinoma of the naso­pharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys 1997;37(5):985–996
6. Sutton JB, Green JP, Meyer JL, Louie D, Heltzel M, Karp AH. Naso­pharyngeal carcinoma. A study examining Asian patients treated in the United States. Am J Clin Oncol 1995;18(4):337–342
7. Chan JY, Wei WI. Critical appraisal of maxillary swing ap­proach for nasopharyngeal carcinoma. Expert Opin Ther Targets 2012;16(Suppl 1):S111–S117
8. Lee AWM, Law SCK, Foo W, et al. Retrospective analysis of pa­tients with nasopharyngeal carcinoma treated during 1976­1985: survival after local recurrence. Int J Radiat Oncol Biol Phys 1993;26(5):773–782
9. Wang CC. Re-irradiation of recurrent nasopharyngeal carcino­ma—treatment techniques and results. Int J Radiat Oncol Biol Phys 1987;13(7):953–956
10. Chua DT, Sham JS, Kwong DL, Wei WI, Au GK, Choy D. Locally re­current nasopharyngeal carcinoma: treatment results for patients with computed tomography assessment. Int J Radiat Oncol Biol Phys 1998;41(2):379–386
11. King WW, Ku PK, Mok CO, Teo PM. Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma: a twelve-year experience. Head Neck 2000;22(3):215–222
12. Fee WE Jr, Moir MS, Choi EC, Goffinet D. Nasopharyngectomy for recurrent nasopharyngeal cancer: a 2- to 17-year follow-up. Arch Otolaryngol Head Neck Surg 2002;128(3):280–284
13. Fee WE Jr, Roberson JB Jr, Goffinet DR. Long-term survival af­ter surgical resection for recurrent nasopharyngeal cancer after radiotherapy failure. Arch Otolaryngol Head Neck Surg 1991;117(11):1233–1236
14. Hsu MM, Hong RL, Ting LL, Ko JY, Sheen TS, Lou PJ. Factors af­fecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: experience with 60 cases. Arch Otolaryngol Head Neck Surg 2001;127(7):798–802
15. Suárez C, Rodrigo JP, Rinaldo A, Langendijk JA, Shaha AR, Ferlito A. Current treatment options for recurrent nasopharyngeal cancer. Eur Arch Otorhinolaryngol 2010;267(12):1811–1824
16. Wu SX, Chua DT, Deng ML, et al. Outcome of fractionated stereo­tactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2007;69(3):761–769
17. Castelnuovo P, Nicolai P, Turri-Zanoni M, et al. Endoscopic endo­nasal nasopharyngectomy in selected cancers. Otolaryngol Head Neck Surg 2013;149(3):424–430
18. Chen AM, Bucci MK, Quivey JM, Garcia J, Eisele DW, Fu KK. Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas. Int J Radiat Oncol Biol Phys 2006;66(4):1044–1050
19. Chen AM, Granchi PJ, Garcia J, Bucci MK, Fu KK, Eisele DW. Local-re­gional recurrence after surgery without postoperative irradiation for carcinomas of the major salivary glands: implications for ad­juvant therapy. Int J Radiat Oncol Biol Phys 2007;67(4):982–987
20. Chan JY, Chow VL, Mok VW, Ho AC, Wei WI. Prediction of surgi­cal outcome using plasma Epstein-Barr virus dna and (18)F-FDG PET-CT scan in recurrent nasopharyngeal carcinoma. Head Neck 2012;34(4):541–545
21. Chan JYW, Wong STS. The role of plasma Epstein-Barr virus DNA in the management of recurrent nasopharyngeal carcinoma. Laryngoscope 2014;124(1):126–130
22. Vlantis AC, Tsang RK, Yu BK, et al. Nasopharyngectomy and surgi­cal margin status: a survival analysis. Arch Otolaryngol Head Neck Surg 2007;133(12):1296–1301
23. Hao SP, Tsang NM, Chang KP, Hsu YS, Chen CK, Fang KH. Na­sopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 53 patients and prognostic factors. Acta Otolaryngol 2008;128(4):473–481
24. To EW, Lai EC, Cheng JH, Pang PC, Williams MD, Teo PM. Naso­pharyngectomy for recurrent nasopharyngeal carcinoma: a review of 31 patients and prognostic factors. Laryngoscope 2002;112(10):1877–1882
25. Hadad G, Bassagasteguy L, Carrau RL, et al. A novel reconstruc­tive technique after endoscopic expanded endonasal approaches: vascular pedicle nasoseptal flap. Laryngoscope 2006;116(10): 1882–1886
26. Fortes FSG, Carrau RL, Snyderman CH, et al. Transpterygoid transposition of a temporoparietal fascia flap: a new method for skull base reconstruction after endoscopic expanded endonasal approaches. Laryngoscope 2007;117(6):970–976
27. Kasemsiri P, Carrau RL, Otto BA, et al. Reconstruction of the ped­icled nasoseptal flap donor site with a contralateral reverse rota­tion flap: technical modifications and outcomes. Laryngoscope 2013;123(11):2601–2604
28. Lee HY, Kim HU, Kim SS, et al. Surgical anatomy of the spheno­palatine artery in lateral nasal wall. Laryngoscope 2002;112(10): 1813–1818
29. Becker AM, Hwang PH. Endoscopic endonasal anatomy of the nasopharynx in a cadaver model. Int Forum Allergy Rhinol 2013;3(4):319–324
30. Caicedo-Granados E, Carrau R, Snyderman CH, et al. Reverse rotation flap for reconstruction of donor site after vascular pedicled nasoseptal flap in skull base surgery. Laryngoscope 2010;120(8):1550–1552
31. Yen RF, Hung RL, Pan MH, et al. 18-fluoro-2-deoxyglucose posi­tron emission tomography in detecting residual/recurrent naso­pharyngeal carcinomas and comparison with magnetic resonance imaging. Cancer 2003;98(2):283–287
32. Chan AT, Ma BB, Lo YM, et al. Phase II study of neoadjuvant car­boplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr vi­rus DNA. J Clin Oncol 2004;22(15):3053–3060
33. Chen L, Cui TT, Wang G, Li LY, Shi WY, Ni XX. Intra-nasal scanning of tumors in nasal cavity and paranasal sinus with endoscopic ul­trasonography [Chinese]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2007;42(1):23–26
276
Nasopharyngectomy
https://t.me/med1917
34. Subramanian V, Ragunath K. Advanced endoscopic imaging: a re­view of commercially available technologies. Clin Gastroenterol Hepatol 2014;12(3):368–76.e1
35. Piazza C, Dessouky O, Peretti G, Cocco D, De Benedetto L, Nicolai P. Narrow-band imaging: a new tool for evaluation of head and neck squamous cell carcinomas. Review of the literature. Acta Otorhi­nolaryngol Ital 2008;28(2):49–54
36. Lin YC, Wang WH. Narrow-band imaging for detecting early recur­rent nasopharyngeal carcinoma. Head Neck 2011;33(4):591–594
37. Ho CY, Lee YL, Chu PY. Use of narrow band imaging in evalua­tion of possible nasopharyngeal carcinoma. Am J Rhinol Allergy 2011;25(2):107–111
38. Thong JF, Loke D, Karumathil Sivasankarannair R, Mok P. Use of narrow-band imaging in detection of nasopharyngeal carcinoma. J Laryngol Otol 2013;127(2):163–169
39. Wen YH, Zhu XL, Lei WB, Zeng YH, Sun YQ, Wen WP. Narrow-band imaging: a novel screening tool for early nasopharyngeal carcino­ma. Arch Otolaryngol Head Neck Surg 2012;138(2):183–188
40. Chen C, Fee W, Chen J, et al. Salvage treatment for locally re­current nasopharyngeal carcinoma (NPC). Am J Clin Oncol 2014;37(4):327–331
41. Kasemsiri P, Prevedello DM, Ditzel L, et al. Surgical treatment of nasopharyngeal malignancies: role of endoscopic endonasal ap­proaches. J Nasopharyngeal Carcinoma 2014;1(14):e14
42. Hsu NI, Shen PH, Chao SS, Ong YK, Li CS. En bloc resection concept for endoscopic endonasal nasopharyngectomy: surgical anatomy and outcome. Chin Med J (Engl) 2014;127(16):2934–2939
43. Ong YK, Solares CA, Lee S, Snyderman CH, Fernandez-Miranda J, Gardner PA. Endoscopic nasopharyngectomy and its role in man­aging locally recurrent nasopharyngeal carcinoma. Otolaryngol Clin North Am 2011;44(5):1141–1154
44. Leung TW, Tung SY, Sze WK, et al. Salvage radiation therapy for lo­cally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2000;48(5):1331–1338
45. Castelnuovo P, Dallan I, Bignami M, et al. Nasopharyngeal endo­scopic resection in the management of selected malignancies: ten­year experience. Rhinology 2010;48(1):84–89
46. Ho AS, Kaplan MJ, Fee WE Jr, Yao M, Sunwoo JB, Hwang PH. Targeted endoscopic salvage nasopharyngectomy for recur­rent nasopharyngeal carcinoma. Int Forum Allergy Rhinol 2012;2(2):166–173
47. Chen MY, Wen WP, Guo X, et al. Endoscopic nasopharyngectomy for locally recurrent nasopharyngeal carcinoma. Laryngoscope 2009;119(3):516–522
48. Eisen MD, Yousem DM, Montone KT, et al. Use of preoperative MR to predict dural, perineural, and venous sinus invasion of skull base tumors. AJNR Am J Neuroradiol 1996;17(10):1937–1945
49. McIntyre JB, Perez C, Penta M, Tong L, Truelson J, Batra PS. Patterns of dural involvement in sinonasal tumors: prospective correlation of magnetic resonance imaging and histopathologic findings. Int Forum Allergy Rhinol 2012;2(4):336–341
50. Ahmadi J, Hinton DR, Segall HD, Couldwell WT. Surgical impli­cations of magnetic resonance-enhanced dura. Neurosurgery 1994;35(3):370–377, discussion 377
51. Ozer E, Waltonen J. Transoral robotic nasopharyngectomy: a novel approach for nasopharyngeal lesions. Laryngoscope 2008;118(9):1613–1616
52. Wei WI, Ho WK. Transoral robotic resection of recurrent nasopha­ryngeal carcinoma. Laryngoscope 2010;120(10):2011–2014
53. Tsang RKY, Ho WK, Wei WI, Chan JY. Transoral robotic assisted nasopharyngectomy via a lateral palatal flap approach. Laryngo­scope 2013;123(9):2180–2183
277
https://t.me/med1917
V
Section 7
https://t.me/med1917
Combined Endoscopic–
27 Transbasal/Subfrontal-
Transcribriform Approach to Anterior Skull Base 281
Transcranial Approaches
28 Retrosigmoid–Transclival
Approach 293
29 Far Lateral-Craniovertebral
Approach 303
30 Anterior Transpetrosal
Approach versus EEA Transclival Approach 315
II
https://t.me/med1917
Chapter 27
https://t.me/med1917
27.1 Indications 282
Transbasal/ Subfrontal-
Transcribriform
Approach to Anterior
Skull Base
27.2 Surgical Steps 282
27.3 Case Example 290
27.4 Complications 291
27.5 Instruments Required 291
27.6 Tips and Tricks 291
Transbasal/Subfrontal-Transcribriform Approach to Anterior Skull Base
https://t.me/med1917
27 Transbasal/Subfrontal-Transcribriform Approach to Anterior Skull Base
Iacopo Dallan, Mario Turri-Zanoni, Stefano Sellari-Franceschini
Introduction
Although there is terrific advancement of endonasal en­doscopic procedures, there are still lesions/conditions of the anterior cranial base that require a combined approach. This kind of approach is mainly indicated in case of sinonasal tumors needing a dural resection extending over the orbital roof or with an extensive brain involvement. Thanks to the combined transcranial/trans­nasal approach and the aid of straight and angled endo­scope, this kind of procedure offers a multiperspective visualization of the spaces allowing a more precise dis­section and a sound reconstruction.
27.1 Indications
The endoscopic transnasal approach is generally com­bined to the transbasal (frontal)/subfrontal approach for addressing different pathologies involving the anterior cranial fossa, not amenable for an exclusive endonasal approach. such an approach are as follows:
Extensive malignant tumors of the anterior skull base,
Benign tumors of the sinonasal compartment with
Inflammatory diseases affecting the frontoethmoid-
Posttraumatic or spontaneous cerebrospinal fluid (CSF)
1
The diseases that can be treated by means of
representing the principal indication for the combined cranio-endoscopic approach. Small- to intermediate
-sized sinonasal cancers can be approached through an exclusive endoscopic transnasal transcribriform– transethmoidal approach.2 However, in cases of extensive anterior skull base involvement with massive infiltration of the dura over the orbital roof or brain parenchyma in­filtration, detected both in the preoperative or intraoper­ative settings, the pure endoscopic transnasal approach should be combined with a transcranial frontal/subfron­tal approach to obtain a radical resection.
massive frontal sinus involvement or intracranial ex­tension over the orbital roof (e.g., inverted papilloma).
al compartments with osteitis and/or osteomyelitis. In these cases, the diseased bone has to be removed through an extended approach to control the infection and limit the progression of the bony erosion.
leaks of the anterior skull base placed in difficult-to­access areas or with an extensive fragmentation of the anterior cranial fossa. In these cases, the exclusive en­donasal approach may be difficult and ineffective.
1,3
27.2 Surgical Steps
The endonasal transcribriform–transethmoidal and the subfrontal/transbasal approaches can be combined and performed simultaneously by two different surgical teams (neurosurgeons and otorhinolaryngologists), working to­gether through the two corridors (multiportal combined transnasal and transcranial endoscopic-assisted surgery). The transcranial approach improves the control of the
supraorbital region and allows a better manipulation of critical structures of anterior cranial base. The transnasal technique allows more precise dissection of the spheno­ethmoidal complex with a better management of the si­nonasal region. the endonasal view is especially useful for completing the skull base reconstruction. Indeed, the endoscope makes it possible to verify the watertight closure and to apply eventually fascia in an overlay fashion, for buttressing the anterior skull base reconstruction. The main surgical steps comprised in such an approach are summarized below.
3
Moreover, at the end of the procedure,
27.2.1 Subtotal Septectomy
Removal of the posterior two-thirds of the nasal septum is performed to gain better exposure of the surgical field and to optimize the endonasal maneuverability of the dedicated instruments, using the two-nostril four-hand technique. The posterior septum is disarticulated from the rostrum of the sphenoid bone, which is then removed to create a bilateral opening in the sphenoid sinus that represents the posteroinferior margin of the dissection. The septal branches of sphenopalatine arteries are isolat­ed and coagulated to reduce bleeding and improve visi­bility (Fig. 27.1).
27.2.2 Identifi cation of the First Olfactory Fiber
The first olfactory fiber is identified in the olfactory re­gion by means of a careful subperiosteal dissection. This is done to define the starting point of the anterior cranial fossa from an endoscopic endonasal perspective; this step is very useful to perform safely a frontal sinusotomy ac­cording to Draf type III. It should be noted that the frontal sinusotomy can be performed also with a lateral to medial direction (this could be advisable in case of difficulties in identifying the first olfactory fiber). This step, absolutely mandatory in exclusively transnasal procedures, could be unnecessary when the frontal sinuses are approached with an additional transcranial opening (Fig. 27.2).
27.2.3 Frontal Sinusotomy (Draf Type III Procedure)
The frontal sinusotomy (see Chapter 4 for detailed descrip­tion) represents the anterosuperior margin of the dissec­tion, allowing a precise control of the lesion to be treated and its relationship with the anterior cranial fossa. The Draf III median drainage consists in the removal of the frontal sinus floor bilaterally together with the intersinus septum. And as said, the Draf type III procedure can be performed using a medial to lateral or a lateral to medial technique. As mentioned before, endonasal frontal sinusotomy can be unnecessary given the superior—transcranial—control of the frontal sinuses (Fig. 27.3).
282
Transbasal/Subfrontal-Transcribriform Approach to Anterior Skull Base
https://t.me/med1917
MT
NS
IT
IT
a
Fig. 27.1 (a) The posterior portion of the nasal septum is removed. (b) Endonasal view of the two ethmoidal complexes after removing the nasal septum. IT, inferior turbinate; MT, middle turbinate; NS, nasal septum; NSup, upper portion of the nasal septum.
b
NSup
MT
FS
OG
MT
Fig. 27.2 Endoscopic endonasal view of the olfactory region (left side). The fi rst olfactory fi ber is indicated by the black arrow. MT, middle turbinate; OG, olfactory groove.
27.2.4 Centripetal Resection of Ethmoidal Box
Once the posteroinferior and anterosuperior margins of the resection are exposed, a subperiosteal dissection of the naso-ethmoidal complexes is performed to de­lineate the lateral borders of the area to be removed. The lamina papyracea should be included in the dis­section when the lesion to treat frankly involved it. When required by the extension of disease, endoscopic
NSup
OM
Fig. 27.3 Endoscopic endonasal view of the frontal sinusotomy according to Draf type III procedure. Once the Draf type III procedure is performed, the “T shape” of the anatomic structures (upper portion of the nasal septum and lateral lamella of the cribriform plates bilaterally) is well evident. FS, frontal sinus; NSup, upper portion of the nasal septum; OM, olfactory mucosa.
medial maxillectomy can be performed, to achieve good control of the whole maxillary sinus. This surgi­cal phase has to be associated with nasolacrimal duct exposure and resection, just below the lacrimal sac. In very selected cases, the periorbita and extraconal fat can be removed, if a very limited involvement of these structures is present (Fig. 27.4).
4
283
Transbasal/Subfrontal-Transcribriform Approach to Anterior Skull Base
https://t.me/med1917
27.2.5 Completion of Centripetal Resection
Superiorly, the dissection is completed, usually with an anteroposterior direction, by resecting the olfac­tory mucosa and the basal lamella of the ethmoidal turbinates, to resect the ethmoidal complexes in a cen­tripetal way. Obviously when doing this step, all the olfactory fibers are cut. The naso-ethmoidal complexes are isolated and pushed toward the central part of the
ASB
MT
MT
nasal fossa (centripetal technique) to extract them through the nasal vestibule or through the oral cavity (Fig. 27.5).
27.2.6 Anterior Cranial Fossa Exposure
The ethmoidal roof should be completely exposed with removal of bony partitions by using a drill with a dia­mond burr. During this step, the anterior and posterior
OG OG
MTMT
4
IT
a
Fig. 27.4 (a) The ethmoidal dissection is shown on the right side. (b) Once the subperiosteal dissection is performed bilaterally, the ethmoidal complexes of both sides remain attached only at the level of the anterior skull base. ASB, anterior skull base; IT, inferior turbinate; MT, middle turbinate; OG, olfactory groove.
FS
NSup
AEA
b
CP
*
*
*
FE
*
a
Fig. 27.5 (a) The ethmoidal boxes are completely resected from the cribriform plates, exposing the anterior skull base. In this way, the anterior and posterior ethmoidal arteries are visible, usually running in bony canals. (b) Once the anterior skull base is denuded from the frontal sinus back to the sphenoid sinus, the olfactory fi bers appear evident. AEA, anterior ethmoidal artery; CP, cribriform plate; FE, fovea ethmoidalis; FS, frontal sinus; NSup, upper portion of the nasal septum; black arrow indicates the posterior ethmoidal artery; black asterisks point out the olfactory fi bers.
b
284